Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 413

1.

Cost analysis and efficacy of recruitment strategies used in a large pragmatic community-based clinical trial targeting low-income seniors: a comparative descriptive analysis.

Kakumanu S, Manns BJ, Tran S, Saunders-Smith T, Hemmelgarn BR, Tonelli M, Tsuyuki R, Ivers N, Southern D, Bakal J, Campbell DJT.

Trials. 2019 Oct 7;20(1):577. doi: 10.1186/s13063-019-3652-5.

2.

Effect on Treatment Adherence of Distributing Essential Medicines at No Charge: The CLEAN Meds Randomized Clinical Trial.

Persaud N, Bedard M, Boozary AS, Glazier RH, Gomes T, Hwang SW, Jüni P, Law MR, Mamdani MM, Manns BJ, Martin D, Morgan SG, Oh PI, Pinto AD, Shah BR, Sullivan F, Umali N, Thorpe KE, Tu K, Laupacis A; Carefully Selected and Easily Accessible at No Charge Medicines (CLEAN Meds) Study Team.

JAMA Intern Med. 2019 Oct 7. doi: 10.1001/jamainternmed.2019.4472. [Epub ahead of print]

PMID:
31589276
3.

Barriers and facilitators for implementation of electronic consultations (eConsult) to enhance access to specialist care: a scoping review.

Osman MA, Schick-Makaroff K, Thompson S, Bialy L, Featherstone R, Kurzawa J, Zaidi D, Okpechi I, Habib S, Shojai S, Jindal K, Braam B, Keely E, Liddy C, Manns B, Tonelli M, Hemmelgarn B, Klarenbach S, Bello AK.

BMJ Glob Health. 2019 Sep 13;4(5):e001629. doi: 10.1136/bmjgh-2019-001629. eCollection 2019.

4.

A Cost Analysis and Cost-Utility Analysis of a Community Pharmacist-Led Intervention on Reducing Cardiovascular Risk: The Alberta Vascular Risk Reduction Community Pharmacy Project (RxEACH).

Tam-Tham H, Clement F, Hemmelgarn BR, Manns BJ, Klarenbach SW, Tonelli M, Tsuyuki RT, Al Hamarneh YN, Penko J, Weaver CGW, Au F, Weaver RG, Jones CA, McBrien KA.

Value Health. 2019 Oct;22(10):1128-1136. doi: 10.1016/j.jval.2019.05.012. Epub 2019 Aug 17.

PMID:
31563255
5.

Influence of Mortality on Estimating the Risk of Kidney Failure in People with Stage 4 Chronic Kidney Disease.

Ravani P, Fiocco M, Liu P, Quinn RR, Hemmelgarn B, James M, Lam N, Manns B, Oliver MJ, Strippoli GFM, Tonelli M.

J Am Soc Nephrol. 2019 Sep 20. pii: ASN.2019060640. doi: 10.1681/ASN.2019060640. [Epub ahead of print]

PMID:
31540963
6.

Correction to: Methods for identifying 30 chronic conditions: application to administrative data.

Tonelli M, Wiebe N, Fortin M, Guthrie B, Hemmelgarn BR, James MT, Klarenbach SW, Lewanczuk R, Manns BJ, Ronksley P, Sargious P, Straus S, Quan H; Alberta Kidney Disease Network.

BMC Med Inform Decis Mak. 2019 Sep 4;19(1):177. doi: 10.1186/s12911-019-0900-2.

7.

Challenges and potential solutions to the evaluation, monitoring, and regulation of surgical innovations.

Roberts DJ, Zygun DA, Ball CG, Kirkpatrick AW, Faris PD, James MT, Mrklas KJ, Hemmelgarn BD, Manns B, Stelfox HT.

BMC Surg. 2019 Aug 27;19(1):119. doi: 10.1186/s12893-019-0586-5.

8.

Association of Mental Health Disorders With Health Care Utilization and Costs Among Adults With Chronic Disease.

Sporinova B, Manns B, Tonelli M, Hemmelgarn B, MacMaster F, Mitchell N, Au F, Ma Z, Weaver R, Quinn A.

JAMA Netw Open. 2019 Aug 2;2(8):e199910. doi: 10.1001/jamanetworkopen.2019.9910.

9.

Alberta's Strategic Clinical Networks: A roadmap for the future.

Manns BJ, Strilchuk A, Mork M, Wasylak T.

Healthc Manage Forum. 2019 Aug 8:840470419867344. doi: 10.1177/0840470419867344. [Epub ahead of print]

PMID:
31394938
10.

Protocol for a pilot randomised controlled trial of an educational programme for adults on chronic haemodialysis with fatigue (Fatigue-HD).

Farragher JF, Thomas C, Ravani P, Manns B, Elliott MJ, Hemmelgarn BR.

BMJ Open. 2019 Jul 30;9(7):e030333. doi: 10.1136/bmjopen-2019-030333.

11.

Attributable costs and length of stay of hospital-acquired Clostridioides difficile: A population-based matched cohort study in Alberta, Canada.

Leal JR, Conly J, Weaver R, Wick J, Henderson EA, Manns B, Ronksley P.

Infect Control Hosp Epidemiol. 2019 Oct;40(10):1135-1143. doi: 10.1017/ice.2019.178. Epub 2019 Jul 25.

PMID:
31342884
12.

A cost-effectiveness analysis of mupirocin and chlorhexidine gluconate for Staphylococcus aureus decolonization prior to hip and knee arthroplasty in Alberta, Canada compared to standard of care.

Rennert-May E, Conly J, Smith S, Puloski S, Henderson E, Au F, Manns B.

Antimicrob Resist Infect Control. 2019 Jul 11;8:113. doi: 10.1186/s13756-019-0568-5. eCollection 2019.

13.

Joint associations of obesity and estimated GFR with clinical outcomes: a population-based cohort study.

Tonelli M, Wiebe N, Kovesdy CP, James MT, Klarenbach SW, Manns BJ, Hemmelgarn BR; Alberta Kidney Disease Network.

BMC Nephrol. 2019 Jun 6;20(1):204. doi: 10.1186/s12882-019-1351-9.

14.

Association Between the Publication of the Initiating Dialysis Early and Late Trial and the Timing of Dialysis Initiation in Canada.

Ferguson TW, Garg AX, Sood MM, Rigatto C, Chau E, Komenda P, Naimark D, Nesrallah GE, Soroka SD, Beaulieu M, Alam A, Kim SJ, Dixon S, Manns B, Tangri N.

JAMA Intern Med. 2019 Jul 1;179(7):934-941. doi: 10.1001/jamainternmed.2019.0489.

PMID:
31135821
15.

The Cost of Care for People With Chronic Kidney Disease.

Manns B, Hemmelgarn B, Tonelli M, Au F, So H, Weaver R, Quinn AE, Klarenbach S; for Canadians Seeking Solutions and Innovations to Overcome Chronic Kidney Disease.

Can J Kidney Health Dis. 2019 Apr 4;6:2054358119835521. doi: 10.1177/2054358119835521. eCollection 2019.

16.

Predictors of mortality and length of stay in patients with hospital-acquired Clostridioides difficile infection: a population-based study in Alberta, Canada.

Leal J, Ronksley P, Henderson EA, Conly J, Manns B.

J Hosp Infect. 2019 Sep;103(1):85-91. doi: 10.1016/j.jhin.2019.04.007. Epub 2019 Apr 13.

PMID:
30991081
17.

Incidence and Prognosis of Acute Kidney Diseases and Disorders Using an Integrated Approach to Laboratory Measurements in a Universal Health Care System.

James MT, Levey AS, Tonelli M, Tan Z, Barry R, Pannu N, Ravani P, Klarenbach SW, Manns BJ, Hemmelgarn BR.

JAMA Netw Open. 2019 Apr 5;2(4):e191795. doi: 10.1001/jamanetworkopen.2019.1795.

18.

Patient and provider experience and perspectives of a risk-based approach to multidisciplinary chronic kidney disease care: a mixed methods study.

Smekal MD, Tam-Tham H, Finlay J, Donald M, Thomas C, Weaver RG, Quinn RR, Tam K, Manns BJ, Tonelli M, Bello A, Tangri N, Hemmelgarn BR.

BMC Nephrol. 2019 Mar 29;20(1):110. doi: 10.1186/s12882-019-1269-2.

19.

Statin use and the risk of acute kidney injury in older adults.

Tonelli M, Lloyd AM, Bello AK, James MT, Klarenbach SW, McAlister FA, Manns BJ, Tsuyuki RT, Hemmelgarn BR; Alberta Kidney Disease Network.

BMC Nephrol. 2019 Mar 25;20(1):103. doi: 10.1186/s12882-019-1280-7.

20.

The impact of pharmaceutical rebates on patients' drug expenditures.

Memedovich KA, Manns B, Beall R, Hollis A, Clement F.

CMAJ. 2019 Mar 18;191(11):E308-E312. doi: 10.1503/cmaj.181041. No abstract available.

PMID:
30885969
21.

Red cell distribution width associations with clinical outcomes: A population-based cohort study.

Tonelli M, Wiebe N, James MT, Naugler C, Manns BJ, Klarenbach SW, Hemmelgarn BR.

PLoS One. 2019 Mar 13;14(3):e0212374. doi: 10.1371/journal.pone.0212374. eCollection 2019.

22.

Nephrology consultation and mortality in people with stage 4 chronic kidney disease: a population-based study.

Liu P, Quinn RR, Karim ME, Bello A, Tam-Tham H, Weaver R, Ronksley PE, Quan H, Strippoli GFM, Manns B, Hemmelgarn BR, Tonelli M, Ravani P.

CMAJ. 2019 Mar 11;191(10):E274-E282. doi: 10.1503/cmaj.181372.

23.

The association between payment model and specialist physicians' selection of patients with diabetes: a descriptive study.

Quinn AE, Edwards A, Senior P, McBrien KA, Hemmelgarn BR, Tonelli M, Au F, Ma Z, Weaver RG, Manns BJ.

CMAJ Open. 2019 Feb 18;7(1):E109-E116. doi: 10.9778/cmajo.20180171. Print 2019 Jan-Mar.

24.

Comparison of the Complexity of Patients Seen by Different Medical Subspecialists in a Universal Health Care System.

Tonelli M, Wiebe N, Manns BJ, Klarenbach SW, James MT, Ravani P, Pannu N, Himmelfarb J, Hemmelgarn BR.

JAMA Netw Open. 2018 Nov 2;1(7):e184852. doi: 10.1001/jamanetworkopen.2018.4852. Erratum in: JAMA Netw Open. 2019 Mar 1;2(3):e190147.

25.

Developing key performance indicators for prescription medication systems.

Spackman E, Clement F, Allan GM, Bell CM, Bjerre LM, Blackburn DF, Blais R, Hazlewood G, Klarenbach S, Nicolle LE, Persaud N, Alessi-Severini S, Tierney M, Wijeysundera HC, Manns B.

PLoS One. 2019 Jan 15;14(1):e0210794. doi: 10.1371/journal.pone.0210794. eCollection 2019.

26.

Exploring structural barriers to diabetes self-management in Alberta First Nations communities.

Kulhawy-Wibe S, King-Shier KM, Barnabe C, Manns BJ, Hemmelgarn BR, Campbell DJT.

Diabetol Metab Syndr. 2018 Dec 3;10:87. doi: 10.1186/s13098-018-0385-7. eCollection 2018.

27.

Psoriatic arthritis screening: a systematic review and meta-analysis.

Iragorri N, Hazlewood G, Manns B, Danthurebandara V, Spackman E.

Rheumatology (Oxford). 2019 Apr 1;58(4):692-707. doi: 10.1093/rheumatology/key314.

PMID:
30380111
28.

Implementing core outcomes in kidney disease: report of the Standardized Outcomes in Nephrology (SONG) implementation workshop.

Tong A, Manns B, Wang AYM, Hemmelgarn B, Wheeler DC, Gill J, Tugwell P, Pecoits-Filho R, Crowe S, Harris T, Van Biesen W, Winkelmayer WC, Levin A, Thompson A, Perkovic V, Ju A, Gutman T, Bernier-Jean A, Viecelli AK, O'Lone E, Shen J, Josephson MA, Cho Y, Johnson DW, Sautenet B, Tonelli M, Craig JC; SONG Implementation Workshop Investigators.

Kidney Int. 2018 Dec;94(6):1053-1068. doi: 10.1016/j.kint.2018.08.018. Epub 2018 Oct 22.

PMID:
30360959
29.

Neprilysin Inhibition and Effects on Kidney Function and Surrogates of Cardiovascular Risk in Chronic Kidney Disease.

James M, Manns B.

Circulation. 2018 Oct 9;138(15):1515-1518. doi: 10.1161/CIRCULATIONAHA.118.036523. No abstract available.

PMID:
30354525
30.

Dialysis Modalities for the Treatment of End-Stage Kidney Disease: A Health Technology Assessment [Internet].

Sinclair A, Cimon K, Loncar M, Sood M, Komenda P, Severn M, Klarenbach S, So H, Tsoi B, Quinn R, Pauly R, Tonelli M, Manns B, Rader T, Moulton K, Moulton K, Helis E, Crain J, Pullman D.

Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2017 Mar.

31.

The cost of managing complex surgical site infections following primary hip and knee arthroplasty: A population-based cohort study in Alberta, Canada.

Rennert-May ED, Conly J, Smith S, Puloski S, Henderson E, Au F, Manns B.

Infect Control Hosp Epidemiol. 2018 Oct;39(10):1183-1188. doi: 10.1017/ice.2018.199. Epub 2018 Sep 10.

PMID:
30196799
32.

Healthcare Costs for the Evaluation, Surgery, and Follow-Up Care of Living Kidney Donors.

Habbous S, Sarma S, Barnieh LJ, McArthur E, Klarenbach S, Manns B, Begen MA, Lentine KL, Garg AX; Donor Nephrectomy Outcomes Research (DONOR) Network.

Transplantation. 2018 Aug;102(8):1367-1374. doi: 10.1097/TP.0000000000002222.

PMID:
30044364
33.

Can economic incentives increase the use of home dialysis?

Manns B, Agar JWM, Biyani M, Blake PG, Cass A, Culleton B, Kleophas W, Komenda P, Lobbedez T, MacRae J, Marshall MR, Scott-Douglas N, Srivastava V, Magner P.

Nephrol Dial Transplant. 2019 May 1;34(5):731-741. doi: 10.1093/ndt/gfy223.

PMID:
30010852
34.

Closed Or Open after Source Control Laparotomy for Severe Complicated Intra-Abdominal Sepsis (the COOL trial): study protocol for a randomized controlled trial.

Kirkpatrick AW, Coccolini F, Ansaloni L, Roberts DJ, Tolonen M, McKee JL, Leppaniemi A, Faris P, Doig CJ, Catena F, Fabian T, Jenne CN, Chiara O, Kubes P, Manns B, Kluger Y, Fraga GP, Pereira BM, Diaz JJ, Sugrue M, Moore EE, Ren J, Ball CG, Coimbra R, Balogh ZJ, Abu-Zidan FM, Dixon E, Biffl W, MacLean A, Ball I, Drover J, McBeth PB, Posadas-Calleja JG, Parry NG, Di Saverio S, Ordonez CA, Xiao J, Sartelli M; Closed Or Open after Laparotomy (COOL) after Source Control for Severe Complicated Intra-Abdominal Sepsis Investigators.

World J Emerg Surg. 2018 Jun 22;13:26. doi: 10.1186/s13017-018-0183-4. eCollection 2018.

35.

Overview of Self-Management Resources Used by Canadian Chronic Kidney Disease Clinics: A National Survey.

Donald M, Gil S, Kahlon B, Beanlands H, Straus S, Herrington G, Manns B, Hemmelgarn BR.

Can J Kidney Health Dis. 2018 May 22;5:2054358118775098. doi: 10.1177/2054358118775098. eCollection 2018.

36.

Troponin T monitoring to detect myocardial injury after noncardiac surgery: a cost-consequence analysis.

Buse GL, Manns B, Lamy A, Guyatt G, Polanczyk CA, Chan MTV, Wang CY, Villar JC, Sigamani A, Sessler DI, Berwanger O, Biccard BM, Pearse R, Urrútia G, Szczeklik W, Garutti I, Srinathan S, Malaga G, Abraham V, Chow CK, Jacka MJ, Tiboni M, Ackland G, Macneil D, Sapsford R, Leuwer M, Le Manach Y, Devereaux PJ.

Can J Surg. 2018 Jun;61(3):185-194.

37.

Survival among older adults with kidney failure is better in the first three years with chronic dialysis treatment than not.

Tam-Tham H, Quinn RR, Weaver RG, Zhang J, Ravani P, Liu P, Thomas C, King-Shier K, Fruetel K, James MT, Manns BJ, Tonelli M, Murtagh FEM, Hemmelgarn BR.

Kidney Int. 2018 Sep;94(3):582-588. doi: 10.1016/j.kint.2018.03.007. Epub 2018 May 24.

PMID:
29803405
38.

Validity of administrative data in identifying complex surgical site infections from a population-based cohort after primary hip and knee arthroplasty in Alberta, Canada.

Rennert-May E, Manns B, Smith S, Puloski S, Henderson E, Au F, Bush K, Conly J.

Am J Infect Control. 2018 Oct;46(10):1123-1126. doi: 10.1016/j.ajic.2018.03.018. Epub 2018 Apr 27.

PMID:
29709393
39.

Clinicians' and researchers' perspectives on establishing and implementing core outcomes in haemodialysis: semistructured interview study.

Tong A, Crowe S, Gill JS, Harris T, Hemmelgarn BR, Manns B, Pecoits-Filho R, Tugwell P, van Biesen W, Wang AYM, Wheeler DC, Winkelmayer WC, Gutman T, Ju A, O'Lone E, Sautenet B, Viecelli A, Craig JC.

BMJ Open. 2018 Apr 20;8(4):e021198. doi: 10.1136/bmjopen-2017-021198.

40.

Health care costs for the evaluation, surgery, and follow-up care of living kidney donors.

Habbous S, Sarma S, Barnieh L, McArthur E, Klarenbach S, Manns B, Begen MA, Lentine KL, Garg AX; Donor Nephrectomy Outcomes Research (DONOR) Network.

Transplantation. 2018 Apr 19. doi: 10.1097/TP.0000000000002222. [Epub ahead of print]

PMID:
29677068
41.

Perceived Benefits and Challenges of a Risk-Based Approach to Multidisciplinary Chronic Kidney Disease Care: A Qualitative Descriptive Study.

Smekal MD, Tam-Tham H, Finlay J, Donald M, Benterud E, Thomas C, Quinn RR, Tam K, Manns BJ, Tonelli M, Bello A, Tangri N, Hemmelgarn BR.

Can J Kidney Health Dis. 2018 Mar 23;5:2054358118763809. doi: 10.1177/2054358118763809. eCollection 2018.

42.

Concentrations of Trace Elements and Clinical Outcomes in Hemodialysis Patients: A Prospective Cohort Study.

Tonelli M, Wiebe N, Bello A, Field CJ, Gill JS, Hemmelgarn BR, Holmes DT, Jindal K, Klarenbach SW, Manns BJ, Thadhani R, Kinniburgh D; Alberta Kidney Disease Network.

Clin J Am Soc Nephrol. 2018 Jun 7;13(6):907-915. doi: 10.2215/CJN.11451017. Epub 2018 Mar 29.

43.

Potential implications of a more timely living kidney donor evaluation.

Habbous S, McArthur E, Sarma S, Begen MA, Lam NN, Manns B, Lentine KL, Dipchand C, Litchfield K, McKenzie S, Garg AX; Donor Nephrectomy Outcomes Research (DONOR) Network.

Am J Transplant. 2018 Nov;18(11):2719-2729. doi: 10.1111/ajt.14732. Epub 2018 Apr 17.

PMID:
29575655
44.

Establishing a Core Outcome Measure for Fatigue in Patients on Hemodialysis: A Standardized Outcomes in Nephrology-Hemodialysis (SONG-HD) Consensus Workshop Report.

Ju A, Unruh M, Davison S, Dapueto J, Dew MA, Fluck R, Germain M, Jassal SV, Obrador G, O'Donoghue D, Josephson MA, Craig JC, Viecelli A, O'Lone E, Hanson CS, Manns B, Sautenet B, Howell M, Reddy B, Wilkie C, Rutherford C, Tong A; SONG-HD Fatigue Workshop Collaborators.

Am J Kidney Dis. 2018 Jul;72(1):104-112. doi: 10.1053/j.ajkd.2017.12.018. Epub 2018 Mar 16.

PMID:
29551585
45.

A population-based cohort study defines prognoses in severe chronic kidney disease.

Tonelli M, Wiebe N, James MT, Klarenbach SW, Manns BJ, Ravani P, Strippoli GFM, Hemmelgarn BR; Alberta Kidney Disease Network.

Kidney Int. 2018 May;93(5):1217-1226. doi: 10.1016/j.kint.2017.12.013. Epub 2018 Mar 7.

PMID:
29525394
46.

Economic evaluations and their use in infection prevention and control: a narrative review.

Rennert-May E, Conly J, Leal J, Smith S, Manns B.

Antimicrob Resist Infect Control. 2018 Feb 27;7:31. doi: 10.1186/s13756-018-0327-z. eCollection 2018. Review.

47.

Report of the Standardized Outcomes in Nephrology-Hemodialysis (SONG-HD) Consensus Workshop on Establishing a Core Outcome Measure for Hemodialysis Vascular Access.

Viecelli AK, Tong A, O'Lone E, Ju A, Hanson CS, Sautenet B, Craig JC, Manns B, Howell M, Chemla E, Hooi LS, Johnson DW, Lee T, Lok CE, Polkinghorne KR, Quinn RR, Vachharajani T, Vanholder R, Zuo L, Hawley CM; SONG-HD Vascular Access Workshop Investigators.

Am J Kidney Dis. 2018 May;71(5):690-700. doi: 10.1053/j.ajkd.2017.12.003. Epub 2018 Feb 23. Review.

PMID:
29478866
48.

Scope and Consistency of Outcomes Reported in Randomized Trials Conducted in Adults Receiving Hemodialysis: A Systematic Review.

Sautenet B, Tong A, Williams G, Hemmelgarn BR, Manns B, Wheeler DC, Tugwell P, van Biesen W, Winkelmayer WC, Crowe S, Harris T, Evangelidis N, Hawley CM, Pollock C, Johnson DW, Polkinghorne KR, Howard K, Gallagher MP, Kerr PG, McDonald SP, Ju A, Craig JC.

Am J Kidney Dis. 2018 Jul;72(1):62-74. doi: 10.1053/j.ajkd.2017.11.010. Epub 2018 Feb 21.

PMID:
29475768
49.

Patient navigators for people with chronic disease: A systematic review.

McBrien KA, Ivers N, Barnieh L, Bailey JJ, Lorenzetti DL, Nicholas D, Tonelli M, Hemmelgarn B, Lewanczuk R, Edwards A, Braun T, Manns B.

PLoS One. 2018 Feb 20;13(2):e0191980. doi: 10.1371/journal.pone.0191980. eCollection 2018. Review.

50.

Supplemental Content

Support Center